NDC 57841-1300

MOVANTIK

Naloxegol Oxalate

MOVANTIK is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Redhill Biopharma Ltd. The primary component is Naloxegol Oxalate.

Product ID57841-1300_046d2fd8-3056-425f-a196-7ff77450368c
NDC57841-1300
Product TypeHuman Prescription Drug
Proprietary NameMOVANTIK
Generic NameNaloxegol Oxalate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-10-01
Marketing CategoryNDA / NDA
Application NumberNDA204760
Labeler NameRedHill Biopharma Ltd
Substance NameNALOXEGOL OXALATE
Active Ingredient Strength13 mg/1
Pharm ClassesOpioid Antagonist [EPC], Opioid Antagonists [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 57841-1300-1

30 TABLET, FILM COATED in 1 BOTTLE (57841-1300-1)
Marketing Start Date2020-10-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "MOVANTIK" or generic name "Naloxegol Oxalate"

NDCBrand NameGeneric Name
0310-1969MOVANTIKnaloxegol oxalate
0310-1970MOVANTIKnaloxegol oxalate
55700-383MOVANTIKnaloxegol oxalate
55700-988MOVANTIKnaloxegol oxalate
57841-1300MOVANTIKnaloxegol oxalate
57841-1301MOVANTIKnaloxegol oxalate

Trademark Results [MOVANTIK]

Mark Image

Registration | Serial
Company
Trademark
Application Date
MOVANTIK
MOVANTIK
86205691 4782846 Live/Registered
AstraZeneca AB
2014-02-27
MOVANTIK
MOVANTIK
86089235 4600146 Live/Registered
AstraZeneca AB
2013-10-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.